RT Journal Article
SR Electronic
T1 Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005041
DO 10.1136/jitc-2022-005041
VO 10
IS 7
A1 Kwon, Minsuk
A1 Kim, Gahyun
A1 Kim, Ryul
A1 Kim, Kyu-Tae
A1 Kim, Seung Tae
A1 Smith, Simon
A1 Mortimer, Peter G S
A1 Hong, Jung Yong
A1 Loembé, Arsene-Bienvenu
A1 Irurzun-Arana, Itziar
A1 Koulai, Loumpiana
A1 Kim, Kyoung-Mee
A1 Kang, Won Ki
A1 Dean, Emma
A1 Park, Woong-Yang
A1 Lee, Jeeyun
YR 2022
UL http://jitc.bmj.com/content/10/7/e005041.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.